Correlation Between Biovie and Seres Therapeutics
Can any of the company-specific risk be diversified away by investing in both Biovie and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biovie and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biovie Inc and Seres Therapeutics, you can compare the effects of market volatilities on Biovie and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biovie with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biovie and Seres Therapeutics.
Diversification Opportunities for Biovie and Seres Therapeutics
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between Biovie and Seres is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Biovie Inc and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Biovie is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biovie Inc are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Biovie i.e., Biovie and Seres Therapeutics go up and down completely randomly.
Pair Corralation between Biovie and Seres Therapeutics
Given the investment horizon of 90 days Biovie Inc is expected to under-perform the Seres Therapeutics. In addition to that, Biovie is 1.41 times more volatile than Seres Therapeutics. It trades about -0.02 of its total potential returns per unit of risk. Seres Therapeutics is currently generating about -0.02 per unit of volatility. If you would invest 654.00 in Seres Therapeutics on August 30, 2024 and sell it today you would lose (562.00) from holding Seres Therapeutics or give up 85.93% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biovie Inc vs. Seres Therapeutics
Performance |
| Timeline |
| Biovie Inc |
| Seres Therapeutics |
Biovie and Seres Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biovie and Seres Therapeutics
The main advantage of trading using opposite Biovie and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biovie position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.| Biovie vs. Inozyme Pharma | Biovie vs. Day One Biopharmaceuticals | Biovie vs. Terns Pharmaceuticals | Biovie vs. Eledon Pharmaceuticals |
| Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |